Background Investigation Methods, Corporate Intelligence & Due Diligence, e-Discovery Techniques, Investigation & Intelligence Feeds, Judgment Enforcement, Legal Enforcement Cases, Legal Ethics & Intelligence, Legal Technology & Intelligence, Witness Credibility Analysis

FDA Approves Lupin’s Pegfilgrastim Biosimilar, ARMLUPEG

Posted by author-avatar
0
Test Logo Transparent 100Px Jvjbpe

Lupin Limited announced on December 1 that it received FDA approval for its biosimilar product, ARMLUPEG (pegfilgrastim-unne).  ARMLUPEG is approved as a 6 mg/0.6 mL single-dose prefilled syringe presentation, referencing Amgen’s NEULASTA. …
By: Goodwin

Newer
Ex Parte Reexamination Keeps Looking Like a Better Post-Grant Option for Patent Defendants
Back to list
Older The Machine Learning “Advent Calendar” Day 9: LOF in Excel

Leave a Reply

Your email address will not be published. Required fields are marked *